188 related articles for article (PubMed ID: 18335050)
1. The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain.
Fukuda T; Kondo Y; Nakagama H
PLoS One; 2008 Mar; 3(3):e1776. PubMed ID: 18335050
[TBL] [Abstract][Full Text] [Related]
2. CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation.
Kashima L; Idogawa M; Mita H; Shitashige M; Yamada T; Ogi K; Suzuki H; Toyota M; Ariga H; Sasaki Y; Tokino T
J Biol Chem; 2012 Apr; 287(16):12975-84. PubMed ID: 22337872
[TBL] [Abstract][Full Text] [Related]
3. Nuclear localization of Chfr is crucial for its checkpoint function.
Kwon YE; Kim YS; Oh YM; Seol JH
Mol Cells; 2009 Mar; 27(3):359-63. PubMed ID: 19326084
[TBL] [Abstract][Full Text] [Related]
4. FHA-RING ubiquitin ligases in cell division cycle control.
Brooks L; Heimsath EG; Loring GL; Brenner C
Cell Mol Life Sci; 2008 Nov; 65(21):3458-66. PubMed ID: 18597043
[TBL] [Abstract][Full Text] [Related]
5. CHFR‑mediated epithelial‑to‑mesenchymal transition promotes metastasis in human breast cancer cells.
Jiang G; Fang H; Shang X; Chen X; Cao F
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880594
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of poly(ADP-ribose) recognition by the multizinc binding domain of checkpoint with forkhead-associated and RING Domains (CHFR).
Oberoi J; Richards MW; Crumpler S; Brown N; Blagg J; Bayliss R
J Biol Chem; 2010 Dec; 285(50):39348-58. PubMed ID: 20880844
[TBL] [Abstract][Full Text] [Related]
7. The auto-ubiquitylation of E3 ubiquitin-protein ligase Chfr at G2 phase is required for accumulation of polo-like kinase 1 and mitotic entry in mammalian cells.
Kim JS; Park YY; Park SY; Cho H; Kang D; Cho H
J Biol Chem; 2011 Sep; 286(35):30615-30623. PubMed ID: 21768102
[TBL] [Abstract][Full Text] [Related]
8. CHFR: a key checkpoint component implicated in a wide range of cancers.
Sanbhnani S; Yeong FM
Cell Mol Life Sci; 2012 May; 69(10):1669-87. PubMed ID: 22159584
[TBL] [Abstract][Full Text] [Related]
9. Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice.
Fu Z; Regan K; Zhang L; Muders MH; Thibodeau SN; French A; Wu Y; Kaufmann SH; Lingle WL; Chen J; Tindall DJ
J Clin Invest; 2009 Sep; 119(9):2714-24. PubMed ID: 19690386
[TBL] [Abstract][Full Text] [Related]
10. CHFR is important for the first wave of ubiquitination at DNA damage sites.
Liu C; Wu J; Paudyal SC; You Z; Yu X
Nucleic Acids Res; 2013 Feb; 41(3):1698-710. PubMed ID: 23268447
[TBL] [Abstract][Full Text] [Related]
11. The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.
Kang D; Chen J; Wong J; Fang G
J Cell Biol; 2002 Jan; 156(2):249-59. PubMed ID: 11807090
[TBL] [Abstract][Full Text] [Related]
12. Yeast Chfr homologs retard cell cycle at G1 and G2/M via Ubc4 and Ubc13/Mms2-dependent ubiquitination.
Loring GL; Christensen KC; Gerber SA; Brenner C
Cell Cycle; 2008 Jan; 7(1):96-105. PubMed ID: 18202552
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression.
Privette LM; González ME; Ding L; Kleer CG; Petty EM
Cancer Res; 2007 Jul; 67(13):6064-74. PubMed ID: 17596595
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the FHA domain of the Chfr mitotic checkpoint protein and its complex with tungstate.
Stavridi ES; Huyen Y; Loreto IR; Scolnick DM; Halazonetis TD; Pavletich NP; Jeffrey PD
Structure; 2002 Jul; 10(7):891-9. PubMed ID: 12121644
[TBL] [Abstract][Full Text] [Related]
15. TOPK and PTEN participate in CHFR mediated mitotic checkpoint.
Shinde SR; Gangula NR; Kavela S; Pandey V; Maddika S
Cell Signal; 2013 Dec; 25(12):2511-7. PubMed ID: 24012691
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction between Chfr and Kif22 controls genomic stability.
Maddika S; Sy SM; Chen J
J Biol Chem; 2009 May; 284(19):12998-3003. PubMed ID: 19321445
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.
Soutto M; Peng D; Razvi M; Ruemmele P; Hartmann A; Roessner A; Schneider-Stock R; El-Rifai W
Cancer; 2010 Sep; 116(17):4033-42. PubMed ID: 20564104
[TBL] [Abstract][Full Text] [Related]
18. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
19. Chfr is required for tumor suppression and Aurora A regulation.
Yu X; Minter-Dykhouse K; Malureanu L; Zhao WM; Zhang D; Merkle CJ; Ward IM; Saya H; Fang G; van Deursen J; Chen J
Nat Genet; 2005 Apr; 37(4):401-6. PubMed ID: 15793587
[TBL] [Abstract][Full Text] [Related]
20. CHFR binds to and regulates MAD2 in the spindle checkpoint through its cysteine-rich domain.
Keller JA; Petty EM
Biochem Biophys Res Commun; 2011 Jun; 409(3):389-93. PubMed ID: 21575600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]